OptiNose, Inc. (NASDAQ:OPTN) Q3 2019 Earnings Conference Call - Final Transcript

Nov 12, 2019 • 04:30 pm ET

Previous

OptiNose, Inc. (NASDAQ:OPTN) Q3 2019 Earnings Conference Call - Final Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Executive
Peter K. Miller

And finally we are successfully completing other important corporate objectives. This includes the licensing agreement for ONZETRA XSAIL, and the ongoing conduct of our chronic sinusitis clinical program. I look forward to our future updates.

Thank you. And I would like to open up the call for Q&A.